Results from Oritavancin Resistance Surveillance Programs (2011 to 2014): Clarification for Using Vancomycin as a Surrogate To Infer Oritavancin Susceptibility

被引:15
作者
Jones, Ronald N. [1 ]
Moeck, Greg [2 ]
Arhin, Francis F. [2 ]
Dudley, Michael N. [3 ]
Rhomberg, Paul R. [1 ]
Mendes, Rodrigo E. [1 ]
机构
[1] JMI Labs, North Liberty, IA USA
[2] Med Co, St Laurent, PQ, Canada
[3] Med Co, San Diego, CA USA
关键词
ACUTE BACTERIAL SKIN; SINGLE-DOSE ORITAVANCIN; IN-VITRO ACTIVITIES; STAPHYLOCOCCUS-AUREUS; STRUCTURE INFECTIONS; LIPOGLYCOPEPTIDE; HOSPITALS; LY333328; AGENTS;
D O I
10.1128/AAC.03029-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Measurement of vancomycin susceptibility has been shown to be highly predictive as a surrogate measure of oritavancin susceptibility among clinically indicated Gram-positive species. Results of studying over 30,000 pathogens (from 2011 to 2014) by cross-susceptibility analysis and determining the poor reproducibility of oritavancin-nonsusceptible results showed nearly perfect surrogate testing accuracy (99.86 to 99.94%). Any isolate of an indicated organism species with locally reproducible oritavancin- nonsusceptible results (extremely rare) should be referred to a reference laboratory for confirmation of the results and determination of the resistance mechanism.
引用
收藏
页码:3174 / 3177
页数:4
相关论文
共 26 条
[1]   In Vivo Activity of Oritavancin in Animal Infection Models and Rationale for a New Dosing Regimen in Humans [J].
Ambrose, Paul G. ;
Drusano, George L. ;
Craig, William A. .
CLINICAL INFECTIOUS DISEASES, 2012, 54 :S220-S228
[2]   Effect of polysorbate 80 on oritavancin binding to plastic surfaces: Implications for susceptibility testing [J].
Arhin, Francis F. ;
Sarmiento, Ingrid ;
Belley, Adam ;
McKay, Geoffrey A. ;
Draghi, Deborah C. ;
Grover, Parveen ;
Sahm, Daniel F. ;
Parr, Thomas R., Jr. ;
Moeck, Gregory .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (05) :1597-1603
[3]   In vitro activities of oritavancin and comparators against meticillin-resistant Staphylococcus aureus (MRSA) isolates harbouring the novel mecC gene [J].
Arhin, Francis F. ;
Sarmiento, Ingrid ;
Moeck, Gregory .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 44 (01) :65-68
[4]   Comparative in vitro activity of oritavancin against recent, genetically diverse, community-associated meticillin-resistant Staphylococcus aureus (MRSA) isolates [J].
Arhin, Francis F. ;
Kurepina, Natalia ;
Sarmiento, Ingrid ;
Parr, Thomas R., Jr. ;
Moeck, Gregory ;
Kreiswirth, Barry .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 35 (01) :93-94
[5]   Comparative in vitro activity of oritavancin against Staphylococcus aureus strains that are resistant, intermediate or heteroresistant to vancomycin [J].
Arhin, Francis F. ;
Sarmiento, Ingrid ;
Parr, Thomas R., Jr. ;
Moeck, Gregory .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (04) :868-870
[6]   Unmet Needs and Prospects for Oritavancin in the Management of Vancomycin-Resistant Enterococcal Infections [J].
Arias, Cesar A. ;
Mendes, Rodrigo E. ;
Stilwell, Matthew G. ;
Jones, Ronald N. ;
Murray, Barbara E. .
CLINICAL INFECTIOUS DISEASES, 2012, 54 :S233-S238
[7]  
Clinical and Laboratory Standards Institute, 2015, M100S25 CLIN LAB STA
[8]  
Clinical and Laboratory Standards Institute, 2015, M02A12 CLIN LAB STAN
[9]   Single-Dose Oritavancin Versus 7-10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study [J].
Corey, G. Ralph ;
Good, Samantha ;
Jiang, Hai ;
Moeck, Greg ;
Wikler, Matthew ;
Green, Sinikka ;
Manos, Paul ;
Keech, Richard ;
Singh, Rajesh ;
Heller, Barry ;
Bubnova, Natalia ;
O'Riordan, William .
CLINICAL INFECTIOUS DISEASES, 2015, 60 (02) :254-262
[10]   Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections [J].
Corey, G. Ralph ;
Kabler, Heidi ;
Mehra, Purvi ;
Gupta, Sandeep ;
Overcash, J. Scott ;
Porwal, Ashwin ;
Giordano, Philip ;
Lucasti, Christopher ;
Perez, Antonio ;
Good, Samantha ;
Jiang, Hai ;
Moeck, Greg ;
O'Riordan, William .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (23) :2180-2190